Author, year (Reference) | RR | CIlow | CIup | Type | N | Location | Exposure | Exposure category | Self-report | Outcome | Source |
Bernard et al 198438 | 0.49 | 0.21 | 2.00 | cc | unk | Yorkshire | Benzene use | All | Yes | NHL incidence | Cancer registry/hospital controls |
Blair et al 199339 | 1.5 | 0.7 | 3.1 | cc | 12 | Iowa/Minnesota | Higher intensity | High | Yes | NHL incidence | Cancer registry/RDD & HCFA |
Dryver et al 200440 | 1.95 | 0.90 | 4.21 | cc | 15 | Sweden | High exposure aromatic HCs | High | Yes | NHL incidence | Cancer registry/Sweden ID no. |
Fabbro-Peray et al 200141 | 5.7 | 1.4 | 23.2 | cc | 8 | France | Cumulative >810 days exposed | High | Yes | NHL incidence | Hospitals/electoral lists |
Franceschi et al 198942 | 1.14 | 0.57 | 2.28 | cc | 15 | Italy | Benzene and solvents | All | Yes | NHL incidence | Hospitals/hospital controls |
Fritschi et al 200543 | 0.31 | 0.06 | 1.50 | cc | 2 | Australia | Substantial (>10 TLV >5 days × 5 yrs) | High | Yes | NHL incidence | Cancer registry/electoral lists |
Gerin et al 199829 | 0.8 | 0.4 | 1.6 | cc | 9 | Montreal | Medium/high | High | Yes | NHL incidence | Hospitals/electoral lists |
Glass et al 200344 | 1.48 | 0.30 | 7.16 | ncc | 2 | Australia | Cumulative exposure >16 ppm-yrs | High | No | NHL incidence | Nested in cohort |
Kato et al 200545 | 1.52 | 0.41 | 5.70 | cc | 7 | New York | Occupational exposure | All | Yes | NHL incidence | Cancer registry/DMV & HCFA |
Mao et al 200046 men | 1.2 | 0.8 | 1.9 | cc | 36 | Canada | Occupational exposure | All | Yes | NHL incidence | Cancer registry/insurance & RDD |
Mao et al 200046 women | 0.6 | 0.2 | 1.8 | cc | 5 | Canada | Occupational exposure | All | Yes | NHL incidence | Cancer registry/insurance & RDD |
Miligi et al 200630 | 1.6 | 1.0 | 2.4 | cc | 58 | Italy | Medium/high intensity | High | Yes | NHL incidence | Hospital & cancer registry/population sample |
Persson & Fredrikson 199947 | 0.8 | 0.1 | 3.8 | cc | 3 | Sweden | Occupational 1 year, 5–45 years earlier | All | Yes | NHL incidence | Hospitals/population registers |
Scherr et al 199248 | 1.2 | 0.5 | 2.6 | cc | unk | Boston | Benzene | All | Yes | NHL incidence | Hospitals/town residency lists |
Schnatter et al 199649 | 0.93 | 0.08 | 7.19 | ncc | 2 | Canada | Intensity (mean ppm) 0.20–0.49 ppm | High | No | NHL mortality | Nested in cohort (petroleum workers) |
Seidler et al 200750 | 1.0 | 0.4 | 2.3 | cc | 11 | Germany | Cumulative >130 ppm-yr | High | Yes | NHL incidence | Hospitals and physicians/population registry |
cc, case-control; CIlow, lower 95 CI; CIup, upper 95 CI; DMV, Department of Motor Vehicles; exposure, the exposure category selected for this meta-analysis; exposure category, described as “High” if results for a high exposure category were used; HC, hydrocarbon; HCFA, Health Core Financing Administration; LR, lymphosarcoma and reticulosarcoma; N, number of cases in the selected exposure category; ncc, nested case control; RDD, random digit dialling; self-report, “Yes” means exposure history based primarily on self-reported work history; source, the source of cases and controls in case-control studies; TLV, threshold limit value; unk, unknown.